CYTARABINE HYDROCHLORIDE

PubChem Notes:

Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)

Molecular Formula: C9H13N3O5


InChI: InChI=1/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/f/h10H2

InChIKey: InChIKey=UHDGCWIWMRVCDJ-GIMVELNWCI
SMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

Names:
    CYTARABINE HYDROCHLORIDE
    1-.beta.-D-Arabinofuranosylcytosine hydrochloride
    4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

Registries:
    PubChem CID 596
    PubChem ID 10390243